222 related articles for article (PubMed ID: 28261810)
1. Geographic exposure risk of variant Creutzfeldt-Jakob disease in US blood donors: a risk-ranking model to evaluate alternative donor-deferral policies.
Yang H; Huang Y; Gregori L; Asher DM; Bui T; Forshee RA; Anderson SA
Transfusion; 2017 Apr; 57(4):924-932. PubMed ID: 28261810
[TBL] [Abstract][Full Text] [Related]
2. Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies.
Correll PK; Law MG; Seed CR; Gust A; Buring M; Dax EM; Keller AJ; Kaldor JM
Vox Sang; 2001 Jul; 81(1):6-11. PubMed ID: 11520409
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment for transmission of variant Creutzfeldt-Jakob disease by transfusion of red blood cells in the United States.
Yang H; Gregori L; Asher DM; Epstein JS; Anderson SA
Transfusion; 2014 Sep; 54(9):2194-201. PubMed ID: 24689837
[TBL] [Abstract][Full Text] [Related]
4. Low risk of variant Creutzfeldt-Jakob disease transmission from blood transfusions in Aotearoa New Zealand suggests donor exclusion policies can be relaxed.
Hayman DTS; Baker MG
N Z Med J; 2023 Aug; 136(1581):66-70. PubMed ID: 37619229
[TBL] [Abstract][Full Text] [Related]
5. Risk of variant Creutzfeldt-Jakob disease transmission by blood transfusion in Australia.
McManus H; Seed CR; Hoad VC; Kiely P; Kaldor JM; Styles CE; Yang H; Law M; Gosbell IB
Vox Sang; 2022 Aug; 117(8):1016-1026. PubMed ID: 35609012
[TBL] [Abstract][Full Text] [Related]
6. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
[TBL] [Abstract][Full Text] [Related]
7. Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
Peden AH; Ritchie DL; Ironside JW
Folia Neuropathol; 2005; 43(4):271-8. PubMed ID: 16416391
[TBL] [Abstract][Full Text] [Related]
8. Insights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the US.
Ponte ML
PLoS Med; 2006 Oct; 3(10):e342. PubMed ID: 17076547
[TBL] [Abstract][Full Text] [Related]
9. Impact of vCJD on blood supply.
Seitz R; von Auer F; Blümel J; Burger R; Buschmann A; Dietz K; Heiden M; Hitzler WE; Klamm H; Kreil T; Kretzschmar H; Nübling M; Offergeld R; Pauli G; Schottstedt V; Volkers P; Zerr I
Biologicals; 2007 Apr; 35(2):79-97. PubMed ID: 17320412
[TBL] [Abstract][Full Text] [Related]
10. Estimation of variant Creutzfeldt-Jakob disease infectivity titers in human blood.
Gregori L; Yang H; Anderson S
Transfusion; 2011 Dec; 51(12):2596-602. PubMed ID: 21645006
[TBL] [Abstract][Full Text] [Related]
11. ['Variant of Creutzfeldt-Jacob disease and blood transfusion'; report of the Dutch Health Council].
van Aken WG
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1444-7. PubMed ID: 11503311
[TBL] [Abstract][Full Text] [Related]
12. Risk of variant Creutzfeldt-Jakob disease in a simulated cohort of Canadian blood donors.
Pozzo di Borgo A; Germain M; O'Brien SF; Delage G; Renaud C; Lewin A
Vox Sang; 2023 Sep; 118(9):738-745. PubMed ID: 37463691
[TBL] [Abstract][Full Text] [Related]
13. Mammalian brain consumption by blood donors in the United States: brains today, deferred tomorrow?
Schreiber GB; Sanchez AM; Garratty G; Nass CC; Tu Y; Busch MP;
Transfusion; 2004 May; 44(5):667-74. PubMed ID: 15104646
[TBL] [Abstract][Full Text] [Related]
14. [Variant Creutzfeldt-Jakob disease in France: estimating the number of cases related to travel to the United Kingdom between 1980 and 1995].
Chadeau-Hyam M; Alpérovitch A
Rev Epidemiol Sante Publique; 2005 Feb; 53(1):15-24. PubMed ID: 15888987
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease.
Cooper JK; Andrews N; Ladhani K; Bujaki E; Minor PD
Vox Sang; 2013 Oct; 105(3):196-204. PubMed ID: 23772892
[TBL] [Abstract][Full Text] [Related]
16. Predictive ability of sequential surveys in determining donor loss from increasingly stringent variant Creutzfeldt-Jakob disease deferral policies.
O'brien SF; Chiavetta JA; Goldman M; Fan W; Nair RC; Sher GD; Vamvakas EC
Transfusion; 2006 Mar; 46(3):461-8. PubMed ID: 16533291
[TBL] [Abstract][Full Text] [Related]
17. Consumption of bovine spongiform encephalopathy (BSE) contaminated beef and the risk of variant Creutzfeldt-Jakob disease.
Chen CC; Wang YH; Wu KY
Risk Anal; 2013 Nov; 33(11):1958-68. PubMed ID: 23755826
[TBL] [Abstract][Full Text] [Related]
18. Risk of variant Creutzfeldt-Jakob disease in France.
Chadeau-Hyam M; Alpérovitch A
Int J Epidemiol; 2005 Feb; 34(1):46-52. PubMed ID: 15649960
[TBL] [Abstract][Full Text] [Related]
19. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
Llewelyn CA; Hewitt PE; Knight RS; Amar K; Cousens S; Mackenzie J; Will RG
Lancet; 2004 Feb; 363(9407):417-21. PubMed ID: 14962520
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland.
Teljeur C; Flattery M; Harrington P; O'Neill M; Moran PS; Murphy L; Ryan M
Transfusion; 2012 Nov; 52(11):2285-93. PubMed ID: 22486387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
